CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
July 12, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has...
CLS and Toronto General Hospital Resume Clinical Trial for Prostate Cancer as Company Receives Approval for Updated Sterilization Process by Health Canada
July 12, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 12, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced it has received...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
July 07, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
July 07, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS Americas Continues Clinical Collaborations from New West Coast Office at Spectrum Office Plaza in Irvine, CA
January 14, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced it has relocated its U.S. headquarters to a new office in the Irvine Spectrum Office...
CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment
January 13, 2021 03:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for high-precision, image-guided laser ablation, today...
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
November 17, 2020 05:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS and Toronto General Hospital Continue Clinical Trial Collaboration Regarding MRI-Guided Laser Ablation Treatment of Prostate Cancer
November 17, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada,...
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
November 04, 2020 05:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
November 04, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...